We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+11.09%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$269B
AUM Growth
+$11B
(+4.3%)
Cap. Flow
-$7.32B
Cap. Flow
% of AUM
-2.72%
Top 10 Holdings %
Top 10 Hldgs %
22.8%
Holding
3,195
New
25
Increased
1,065
Reduced
1,860
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 2 |
NVIDIA
NVDA
|
+$425M |
| 3 |
Boeing
BA
|
+$396M |
| 4 |
Linde
LIN
|
+$381M |
| 5 |
ExxonMobil
XOM
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.4B |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$323M |
| 3 |
Accenture
ACN
|
+$264M |
| 4 |
Microsoft
MSFT
|
+$258M |
| 5 |
Union Pacific
UNP
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 13.1% |
| 3 | Financials | 11.54% |
| 4 | Consumer Discretionary | 10.68% |
| 5 | Industrials | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Hanmi Financial
HAFC
$946M
| $2.41M | ﹤0.01% |
129,547
-18,188
| -12% | -$413K |
|
2227
Ooma
OOMA
$604M
| $2.41M | ﹤0.01% |
192,308
-78,324
| -29% | -$1.05M |
|
|
CCF
2228
DELISTED
Chase Corporation
CCF
| $2.4M | ﹤0.01% |
22,861
-33,198
| -59% | -$3.18M |
|
2229
Rocket Lab Corp
RKLB
$51.8B
| $2.39M | ﹤0.01% |
591,984
-24,288
| -4% | -$109K |
|
2230
The GEO Group
GEO
$4.04B
| $2.39M | ﹤0.01% |
302,931
-259,369
| -46% | -$2.54M |
|
2231
York Water
YORW
$514M
| $2.39M | ﹤0.01% |
53,463
+12,031
| +29% | +$538K |
|
2232
Bally's
BALY
$658M
| $2.37M | ﹤0.01% |
121,591
-13,905
| -10% | -$273K |
|
2233
Vanguard Morningstar Small-Cap ETF
VB
$82.4B
| $2.37M | ﹤0.01% |
12,500
-48,500
| -80% | -$9.41M |
|
|
SCU
2234
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $2.34M | ﹤0.01% |
271,858
+12,137
| +5% | +$109K |
|
2235
Pilgrim's Pride
PPC
$6.54B
| $2.33M | ﹤0.01% |
100,439
-144,396
| -59% | -$3.5M |
|
|
VERV
2236
DELISTED
Verve Therapeutics
VERV
| $2.32M | ﹤0.01% |
160,724
-27,750
| -15% | -$543K |
|
|
CHCT
2237
Community Healthcare Trust
CHCT
$454M
| $2.31M | ﹤0.01% |
63,133
-31,141
| -33% | -$1.21M |
|
2238
Plains GP Holdings
PAGP
$4.9B
| $2.31M | ﹤0.01% |
176,002
-4,681
| -3% | -$61.4K |
|
2239
Metallus
MTUS
$898M
| $2.3M | ﹤0.01% |
125,445
-13,867
| -10% | -$259K |
|
|
TBI
2240
Trueblue
TBI
$311M
| $2.3M | ﹤0.01% |
129,014
-179,212
| -58% | -$3.35M |
|
2241
1st Source
SRCE
$2.12B
| $2.29M | ﹤0.01% |
53,087
+889
| +2% | +$43.4K |
|
2242
Sturm, Ruger & Co
RGR
$593M
| $2.27M | ﹤0.01% |
39,584
-2,552
| -6% | -$142K |
|
2243
Biglari Holdings Class B
BH
$1.21B
| $2.27M | ﹤0.01% |
13,433
-420
| -3% | -$69.4K |
|
2244
Ribbon Communications
RBBN
$383M
| $2.27M | ﹤0.01% |
663,904
-25,693
| -4% | -$93.9K |
|
2245
Enanta Pharmaceuticals
ENTA
$400M
| $2.27M | ﹤0.01% |
56,096
-5,284
| -9% | -$252K |
|
2246
SandRidge Energy
SD
$503M
| $2.26M | ﹤0.01% |
156,870
+69,207
| +79% | +$1.06M |
|
2247
Tootsie Roll Industries
TR
$2.98B
| $2.26M | ﹤0.01% |
55,000
-45
| -0.1% | -$1.79K |
|
2248
Vanguard FTSE Developed Markets ETF
VEA
$236B
| $2.26M | ﹤0.01% |
50,000
| – | – |
|
|
TELL
2249
DELISTED
Tellurian Inc.
TELL
| $2.25M | ﹤0.01% |
1,830,758
-2,127,905
| -54% | -$3.39M |
|
2250
SelectQuote
SLQT
$121M
| $2.25M | ﹤0.01% |
1,037,140
+515,419
| +99% | +$832K |
|
Similar funds
VFT
Nuveen's Q1 2023 Portfolio in Review
As of Q1 2023, Nuveen held 3,195 positions worth $269B, up 4.3% from $258B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 3.3%. Nuveen opened 25 new positions and exited 81, leaving the 3,195-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q1 2023 buy was GE HealthCare: 1,240,905 shares worth $102M.
- Nuveen added most to Meta Platforms (Facebook) in Q1 2023, an estimated $1.08B increase.
- Nuveen's biggest Q1 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $1.4B.
- Nuveen fully exited SVB Financial Group in Q1 2023, selling an estimated $51.6M.
- Nuveen's ten largest holdings make up 23% of its $269B portfolio in Q1 2023.
- Nuveen opened 25 new positions and closed 81 in Q1 2023.
- Nuveen's portfolio value rose 4.3% quarter-over-quarter to $269B.
Based on Nuveen's 13F filing for Q1 2023, filed 15 May 2023.